Can a One-Time gene shot calm inflammation in ALS?
Disease control
Not yet recruiting
This early-stage trial is testing whether a single injection of XT-150, a gene therapy that produces an anti-inflammatory protein, is safe for people with ALS. Eight adults with ALS will receive one of two doses and be followed for six months. The goal is to check for side effect…
Phase: PHASE1 • Sponsor: Xalud Therapeutics, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC